This study used the Mother-Child EPI-MERES Register, and analyzed all live births in France from pregnancies that began between April 1, 2021, and January 31, 2022. This research evaluated 527,564 eligible live-born infants, of whom 130,338 (about 24.7%) were exposed to at least one dose of an mRNA-based COVID-19 vaccine (either Pfizer-BioNTech or Moderna) during their first trimester.
To determine whether early vaccination posed any increased risk, this study compared rates of MCMs between infants exposed and unexposed to vaccination in early pregnancy. These malformations were identified according to the European Surveillance of Congenital Anomalies (EUROCAT) guidelines and categorized across 13 organ systems, which encompassed 75 specific birth defects ranging from heart and neural anomalies to limb and abdominal wall malformations.
According to the data, the prevalence of MCMs was similar between the groups: 176.6 cases per 10,000 births among vaccinated mothers versus 179.4 per 10,000 among unvaccinated mothers. After adjusting for maternal age, social status, and comorbidities using a propensity score–based model, the weighted odds ratio for any MCM was 0.98 (95% confidence interval [CI], 0.93–1.04), which showed no statistically significant difference.
When broken down by organ system, none showed elevated risk associated with vaccination. For example, the odds ratio for digestive system malformations was 0.84 (95% CI, 0.68–1.04), while for abdominal wall defects it was 1.20 (95% CI, 0.75–1.91), both within non-significant ranges. Similarly, no specific congenital condition among the 75 examined displayed any increased incidence linked to first-trimester vaccination.
Overall, the study provides strong population-based evidence that mRNA COVID-19 vaccination during early pregnancy does not elevate the risk of congenital abnormalities. These findings offer crucial reassurance to expectant mothers and healthcare providers alike, strengthening the safety profile of mRNA vaccines during all stages of pregnancy.
Source:
Bernard, C., Duchemin, T., Marty, L., Drouin, J., Miranda, S., Semenzato, L., Botton, J., Chouchana, L., Dray-Spira, R., Weill, A., & Zureik, M. (2025). First-trimester mRNA COVID-19 vaccination and risk of major Congenital Anomalies. JAMA Network Open, 8(10), e2538039. https://doi.org/10.1001/jamanetworkopen.2025.38039
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.